NCT05692830

Brief Summary

The study will employ a combined laboratory-ambulatory design. Participants will engage in ambulatory assessment over the course of 14 days, wearing biosensors assessing transdermal alcohol concentration (TAC) and providing breathalyzer readings in real-world contexts. Also during this period, participants will attend three laboratory alcohol-administration sessions scheduled at one-week intervals, with alcohol dose and rate of consumption manipulated within and between participants, respectively. Laboratory visits will also double as ambulatory orientation, check-in, and close-out sessions.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for all trials

Timeline
16mo left

Started Oct 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Oct 2022Sep 2027

First Submitted

Initial submission to the registry

October 20, 2022

Completed
2 days until next milestone

Study Start

First participant enrolled

October 22, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 20, 2023

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

August 6, 2025

Status Verified

August 1, 2025

Enrollment Period

3.8 years

First QC Date

October 20, 2022

Last Update Submit

August 2, 2025

Conditions

Keywords

transdermal alcohol contentambulatorytransdermal biosensormachine learning algorithmsbreath alcohol content

Outcome Measures

Primary Outcomes (3)

  • Transdermal estimates of alcohol consumption

    We will assess the accuracy of transdermal estimates of drinking vs sobriety

    Across the 14 day period of the study

  • Transdermal estimates of drinking risk level

    We will assess the accuracy of transdermal estimates of high risk drinking vs low risk drinking and sobriety

    Across the 14 day period of the study

  • Transdermal estimates of blood alcohol concentration

    We will assess the accuracy of transdermal estimates of blood alcohol concentration (BAC)

    Across the 14 day period of the study

Interventions

Alcohol administered orally at multiple doses and consumption speeds to test transdermal device accuracy

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Regular healthy drinkers aged 21+

You may qualify if:

  • years or older
  • drink alcohol at least 2x weekly

You may not qualify if:

  • psychological or medical conditions that might contraindicate alcohol-administration
  • history of adverse reaction to type and amount of beverage used in the study
  • currently seeking treatment for alcohol use disorder
  • does not drink alcohol regularly
  • taking drugs or medications for which alcohol consumption would be contraindicated
  • women who are pregnant or are attempting to become pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Illinois at Urbana-Champaign

Champaign, Illinois, 61820, United States

RECRUITING

Related Publications (27)

  • Kornacki B, Szreterowa M, Jablonska-Budajowa U, Goryszewska-Maciochowa H. [Transciliary lensectomy]. Klin Oczna. 1983 Nov-Dec;85(11-12):421-3. No abstract available. Polish.

    PMID: 6668891BACKGROUND
  • Bragg DG. Radiologic manpower. Issues and controversies. Invest Radiol. 1987 Jun;22(6):515. doi: 10.1097/00004424-198706000-00015. No abstract available.

    PMID: 3623856BACKGROUND
  • Leemhuis MP, Blom PS, Koevoet A. [Beta-carotene loading test as a screening test for steatorrhea]. Ned Tijdschr Geneeskd. 1971 Sep 11;115(37):1527-30. No abstract available. Dutch.

    PMID: 5569301BACKGROUND
  • Haxby DG, Rodriguez GS, Zechnich AD, Schuff RA, Tanigawa JS. Manufacturers' distribution of drug samples to a family medicine clinic. Am J Health Syst Pharm. 1995 Mar 1;52(5):496-9. doi: 10.1093/ajhp/52.5.496.

    PMID: 7606553BACKGROUND
  • Graham-Pole J. Treating acute lymphoblastic leukaemia after relapse: bone marrow transplantation or not? Lancet. 1989 Dec 23-30;2(8678-8679):1517-8. doi: 10.1016/s0140-6736(89)92953-x. No abstract available.

    PMID: 2574782BACKGROUND
  • Murdaugh HV Jr, Robin ED, Millen JE, Drewry WF, Weiss E. Adaptations to diving in the harbor seal: cardiac output during diving. Am J Physiol. 1966 Jan;210(1):176-80. doi: 10.1152/ajplegacy.1966.210.1.176. No abstract available.

    PMID: 5323319BACKGROUND
  • Lange DE. [Use of antibiotics in periodontal problem cases for prevention of bacteremia and prophylaxis of bacterial endocarditis]. Quintessenz. 1988 Jun;39(6):1047-51. No abstract available. German.

    PMID: 3217504BACKGROUND
  • Griesbach WE, Chaikoff IL, Nichols CW Jr, Goldberg RC. Formation of adenomata in hypophyses of rats subjected to both subtotal thyroidectomy and administration of 131-I, and its prevention by feeding of desiccated thyroid. Cancer Res. 1965 Nov;25(10):1804-16. No abstract available.

    PMID: 4159387BACKGROUND
  • Vihma Y, Korppi-Tommola T, Parkkulainen KV. Pelviureteric obstruction in children: the effect of pyeloplasty on 99mTc-DTPA uptake and washout. Z Kinderchir. 1984 Dec;39(6):358-63. doi: 10.1055/s-2008-1044245.

    PMID: 6395541BACKGROUND
  • Martelli MF, Falini B, Tabilio A, Aversa F. Topographical localization of intracellular immunoglobulins in hairy cells by immunoelectron microscopy. Acta Haematol. 1980;64(5):251-5. doi: 10.1159/000207277.

    PMID: 6779481BACKGROUND
  • Van Iddekinge B. Ectopic pregnancy: a review. S Afr Med J. 1972 Nov 25;46(47):1844-9. No abstract available.

    PMID: 4265311BACKGROUND
  • Molthan L, Crawford MN. Three examples of anti-Lub and related data. Transfusion. 1966 Nov-Dec;6(6):584-9. doi: 10.1111/j.1537-2995.1966.tb04782.x. No abstract available.

    PMID: 5951618BACKGROUND
  • Kopysc Z, Barczyk K, Krol E. [A new syndrome in the group of euhydrotic ectodermal dysplasias]. Pediatr Pol. 1986 Dec;61(12):790-7. No abstract available. Polish.

    PMID: 3601483BACKGROUND
  • Aitio A. Effect of chrysene and carbon tetrachloride administration on rat hepatic microsomal monooxygenase and UDPglucuronosyltransferase activity. FEBS Lett. 1974 May 15;42(1):46-9. doi: 10.1016/0014-5793(74)80275-9. No abstract available.

    PMID: 4211953BACKGROUND
  • Schmidt W, Merz WE, Lenhard V, Kubli F. Effects of crude and purified human chorionic gonadotropin on lymphocyte response. Gynecol Obstet Invest. 1981;12(3):132-40. doi: 10.1159/000299595.

    PMID: 6453759BACKGROUND
  • Hall R, Ramaiah RS, Jones DT. General practitioner hospitals: coming or going? Br Med J (Clin Res Ed). 1984 Jun 2;288(6431):1691. doi: 10.1136/bmj.288.6431.1691-a. No abstract available.

    PMID: 6426692BACKGROUND
  • Burke PM, Jancar J. Sensory and motor defect in severe mental subnormality. Ir J Med Sci. 1969 Oct;8(10):463-8. doi: 10.1007/BF02958617. No abstract available.

    PMID: 5364076BACKGROUND
  • Clarke ED, Goulding KH, Wardman P. Nitroimidazoles as anaerobic electron acceptors for xanthine oxidase. Biochem Pharmacol. 1982 Oct 15;31(20):3237-42. doi: 10.1016/0006-2952(82)90556-1.

    PMID: 6897358BACKGROUND
  • Heidrich HG, Strych W, Prehm P. Spontaneously released Plasmodium falciparum merozoites from culture possess glycoproteins. Z Parasitenkd. 1984;70(6):747-51. doi: 10.1007/BF00927127.

    PMID: 6395533BACKGROUND
  • Miller TR. 100 cases of hemipelvectomy: a personal experience. Surg Clin North Am. 1974 Aug;54(4):905-13. doi: 10.1016/s0039-6109(16)40396-8. No abstract available.

    PMID: 4428322BACKGROUND
  • Ladwa RA. Comparison of Syndol and paracetamol in the relief of dental pain. Br Dent J. 1981 Apr 7;150(7):187-8. doi: 10.1038/sj.bdj.4804571. No abstract available.

    PMID: 6938217BACKGROUND
  • Hoskins IA, Hemming VG, Johnson TR, Winkel CA. Effects of alterations of zinc-to-phosphorus ratios and meconium content on group B Streptococcus growth in human amniotic fluid in vitro. Am J Obstet Gynecol. 1987 Sep;157(3):770-3. doi: 10.1016/s0002-9378(87)80047-9.

    PMID: 3307431BACKGROUND
  • Kirsch WM, Stears JC. Radiographic identification and surgical excision of an epidermoid tumor of the pineal gland. Case report. J Neurosurg. 1970 Dec;33(6):708-13. doi: 10.3171/jns.1970.33.6.0708. No abstract available.

    PMID: 5312639BACKGROUND
  • Agrawal HC, Fishman MA, Prensky AL. A possible block in the intermediary metabolism of glucose into proteins and lipids in the brains of undernourished rats. Lipids. 1971 Jun;6(6):431-3. doi: 10.1007/BF02531382. No abstract available.

    PMID: 4330106BACKGROUND
  • Kanerud L, Hafstrom I. [Acute arthritis and subcutaneous fat necrosis as the first symptom of pancreatic cancer]. Lakartidningen. 1986 Feb 19;83(8):609-10. No abstract available. Swedish.

    PMID: 3951286BACKGROUND
  • Ritter D. The need for risk assessment legislation. Risk Anal. 1988 Jun;8(2):169-70. doi: 10.1111/j.1539-6924.1988.tb01166.x. No abstract available.

    PMID: 3413308BACKGROUND
  • Shah GN, Li J, Schneiderjohn P, Mooradian AD. Cloning and characterization of a complementary DNA for a thyroid hormone-responsive protein in mature rat cerebral tissue. Biochem J. 1997 Oct 15;327 ( Pt 2)(Pt 2):617-23. doi: 10.1042/bj3270617.

    PMID: 9359437BACKGROUND

MeSH Terms

Conditions

Alcohol DrinkingAlcoholic Intoxication

Interventions

Ethanol

Condition Hierarchy (Ancestors)

Drinking BehaviorBehaviorAlcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Study Officials

  • Catharine Fairbairn, PhD

    University of Illinois Urbana-Champaign

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Catharine Fairbairn, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 20, 2022

First Posted

January 20, 2023

Study Start

October 22, 2022

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

September 1, 2027

Last Updated

August 6, 2025

Record last verified: 2025-08

Locations